MedPath

DENTI BOUNGIORNO PLAQUE CARE TOOTH

Approved
Approval ID

3488b090-c30d-e6d2-e063-6294a90a3569

Product Type

HUMAN OTC DRUG LABEL

Effective Date

May 7, 2025

Manufacturers
FDA

ATOSAFE CO., Ltd

DUNS: 688995680

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Silica, Sodium Fluoride, Tocopheryl Acetate, Tetrasodium Pyrophosphate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code85601-020
Product Classification
G
Generic Name
Silica, Sodium Fluoride, Tocopheryl Acetate, Tetrasodium Pyrophosphate
Product Specifications
Route of AdministrationORAL
Effective DateMay 7, 2025
FDA Product Classification

INGREDIENTS (8)

SODIUM PYROPHOSPHATEActive
Quantity: 0.5 g in 100 g
Code: O352864B8Z
Classification: ACTIB
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
SILICON DIOXIDEActive
Quantity: 17 g in 100 g
Code: ETJ7Z6XBU4
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM FLUORIDEActive
Quantity: 0.22 g in 100 g
Code: 8ZYQ1474W7
Classification: ACTIM
SODIUM COCOYL GLUTAMATEInactive
Code: BMT4RCZ3HG
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
.ALPHA.-TOCOPHEROL ACETATEActive
Quantity: 0.2 g in 100 g
Code: 9E8X80D2L0
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DENTI BOUNGIORNO PLAQUE CARE TOOTH - FDA Drug Approval Details